about
Cardioprotective effects of voluntary exercise in a rat model: role of matrix metalloproteinase-2.Endogenous Estrogen-Mediated Heme Oxygenase Regulation in Experimental Menopause.Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient RatTranscriptional Alterations by Ischaemic Postconditioning in a Pig Infarction Model: Impact on Microvascular ProtectionEffect of Ischemic Preconditioning and Postconditioning on Exosome-Rich Fraction microRNA Levels, in Relation with Electrophysiological Parameters and Ventricular Arrhythmia in Experimental Closed-Chest Reperfused Myocardial Infarction.MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ Porcine Cardiac Progenitor Cells In VitroLiposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistanceCatalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
P50
Q35271707-ADF9DE7B-0B7A-45B0-A309-3B2A2340921FQ35625937-1EBD24EA-64BC-489D-B6D7-6A60174348D4Q41100659-F99E1B35-617D-4172-AC96-CFFF16EF9BE5Q61816867-81565E75-8202-4E13-86CA-57859FB153A7Q64940600-268CB1C7-040C-4D5A-AC88-733C0E9E12F2Q91253007-C5FBAD8C-F035-4BE5-9E9C-03D1FA1785F8Q92189426-B12FAA06-5C1D-44EF-9DA5-A07383C134C9Q92757635-592B4ADF-1973-4E95-9121-1182BB290448
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mariann Gyöngyösi
@ast
Mariann Gyöngyösi
@en
Mariann Gyöngyösi
@es
Mariann Gyöngyösi
@nl
type
label
Mariann Gyöngyösi
@ast
Mariann Gyöngyösi
@en
Mariann Gyöngyösi
@es
Mariann Gyöngyösi
@nl
prefLabel
Mariann Gyöngyösi
@ast
Mariann Gyöngyösi
@en
Mariann Gyöngyösi
@es
Mariann Gyöngyösi
@nl
P106
P31
P496
0000-0002-7083-2107